Emerging drugs for small-cell lung cancer.

Emerging drugs for small-cell lung cancer.

Item
http://www.wikidata.org/entity/Q37582918
Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathwayImmunotherapy treatments for small-cell lung cancer: past, present and future.Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.Emerging drugs for small cell lung cancer--an update.Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting.Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.
P2860

Emerging drugs for small-cell lung cancer.

Item
http://www.wikidata.org/entity/Q37582918
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging drugs for small-cell lung cancer.
@en
Emerging drugs for small-cell lung cancer.
@nl
type
label
Emerging drugs for small-cell lung cancer.
@en
Emerging drugs for small-cell lung cancer.
@nl
prefLabel
Emerging drugs for small-cell lung cancer.
@en
Emerging drugs for small-cell lung cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Emerging drugs for small-cell lung cancer.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698